CN105021817A - 一种人体液的显色法真菌1,3-β-D-葡聚糖检测试剂盒 - Google Patents
一种人体液的显色法真菌1,3-β-D-葡聚糖检测试剂盒 Download PDFInfo
- Publication number
- CN105021817A CN105021817A CN201410166572.7A CN201410166572A CN105021817A CN 105021817 A CN105021817 A CN 105021817A CN 201410166572 A CN201410166572 A CN 201410166572A CN 105021817 A CN105021817 A CN 105021817A
- Authority
- CN
- China
- Prior art keywords
- callose
- body fluid
- detection kit
- human body
- development process
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 42
- 241000233866 Fungi Species 0.000 title claims abstract description 38
- 241000282414 Homo sapiens Species 0.000 title claims abstract description 23
- 210000001124 body fluid Anatomy 0.000 title claims abstract description 22
- 239000010839 body fluid Substances 0.000 title claims abstract description 22
- 229920002498 Beta-glucan Polymers 0.000 title abstract 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 title abstract 3
- 210000000601 blood cell Anatomy 0.000 claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229920001184 polypeptide Polymers 0.000 claims abstract description 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 19
- 108010065152 Coagulase Proteins 0.000 claims abstract description 14
- 241001529572 Chaceon affinis Species 0.000 claims abstract description 10
- 238000003908 quality control method Methods 0.000 claims abstract description 10
- JLXVRFDTDUGQEE-YFKPBYRVSA-N Gly-Arg Chemical compound NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N JLXVRFDTDUGQEE-YFKPBYRVSA-N 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 229920000018 Callose Polymers 0.000 claims description 56
- 238000002360 preparation method Methods 0.000 claims description 33
- 241000239218 Limulus Species 0.000 claims description 26
- 238000011161 development Methods 0.000 claims description 23
- 239000003593 chromogenic compound Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 15
- 210000004027 cell Anatomy 0.000 claims description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 11
- 239000013592 cell lysate Substances 0.000 claims description 10
- 239000006166 lysate Substances 0.000 claims description 10
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 9
- 230000004913 activation Effects 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 108010048121 pro-clotting enzyme Proteins 0.000 claims description 7
- 210000002966 serum Anatomy 0.000 claims description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 238000010241 blood sampling Methods 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 6
- 230000008014 freezing Effects 0.000 claims description 6
- 239000003112 inhibitor Substances 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 238000002835 absorbance Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 229940122055 Serine protease inhibitor Drugs 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 239000003001 serine protease inhibitor Substances 0.000 claims description 4
- JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 101710102218 Serine protease inhibitor Proteins 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 239000003708 ampul Substances 0.000 claims description 3
- 244000309466 calf Species 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims description 3
- 235000021050 feed intake Nutrition 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 238000010257 thawing Methods 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 claims description 3
- 108010071063 butyloxycarbonyl-leucyl-glycyl-arginine-4-nitroanilide Proteins 0.000 claims description 2
- 238000005336 cracking Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 4
- 238000004848 nephelometry Methods 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 abstract 3
- 239000000758 substrate Substances 0.000 abstract 3
- 102000010911 Enzyme Precursors Human genes 0.000 abstract 1
- 108010062466 Enzyme Precursors Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000001976 enzyme digestion Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 229920001503 Glucan Polymers 0.000 description 12
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000002538 fungal effect Effects 0.000 description 4
- 241000239222 Tachypleus Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000013062 quality control Sample Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000003805 vibration mixing Methods 0.000 description 3
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 2
- 241000223218 Fusarium Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000012916 chromogenic reagent Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 244000053095 fungal pathogen Species 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241001136487 Eurotium Species 0.000 description 1
- 206010017523 Fungaemia Diseases 0.000 description 1
- 208000023661 Haematological disease Diseases 0.000 description 1
- 241000228404 Histoplasma capsulatum Species 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 208000037026 Invasive Fungal Infections Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 241000233872 Pneumocystis carinii Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004523 agglutinating effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410166572.7A CN105021817B (zh) | 2014-04-24 | 2014-04-24 | 一种人体液的显色法真菌1,3‑β‑D‑葡聚糖检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410166572.7A CN105021817B (zh) | 2014-04-24 | 2014-04-24 | 一种人体液的显色法真菌1,3‑β‑D‑葡聚糖检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105021817A true CN105021817A (zh) | 2015-11-04 |
CN105021817B CN105021817B (zh) | 2017-02-15 |
Family
ID=54411938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410166572.7A Active CN105021817B (zh) | 2014-04-24 | 2014-04-24 | 一种人体液的显色法真菌1,3‑β‑D‑葡聚糖检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105021817B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104483495A (zh) * | 2014-11-13 | 2015-04-01 | 湛江安度斯生物有限公司 | 一种消除g试验假阳性干扰的方法 |
CN106290890A (zh) * | 2016-07-15 | 2017-01-04 | 科赫生物科技(北京)有限公司 | 一种改良的人体液显色法真菌1,3‑β‑D‑葡聚糖检测试剂盒及其应用方法 |
CN106974876A (zh) * | 2017-03-14 | 2017-07-25 | 天津喜诺生物医药有限公司 | 一种由鲎细胞裂解液制备眼部护理液的方法 |
CN108642131A (zh) * | 2018-04-17 | 2018-10-12 | 山东仕达思生物产业有限公司 | 一种凝固酶检测试剂、反应垫及其制备方法和试剂盒 |
CN108663509A (zh) * | 2017-06-16 | 2018-10-16 | 江苏诺鬲生物科技有限公司 | 一种标记真菌的免疫显色试剂 |
CN109868216A (zh) * | 2019-04-01 | 2019-06-11 | 丹娜(天津)生物科技有限公司 | 一种简化的真菌1-3-β-D葡聚糖检测试剂盒 |
CN112625145A (zh) * | 2020-11-25 | 2021-04-09 | 昆明思安生物科技有限公司 | 1,3-β-D葡聚糖衍生物、试剂盒及制备方法及测定1,3-β-D葡聚糖含量的方法 |
CN113092767A (zh) * | 2021-04-02 | 2021-07-09 | 丹娜(天津)生物科技股份有限公司 | 一种鲎试剂冻干微球及其制备方法和应用 |
CN115236337A (zh) * | 2022-09-21 | 2022-10-25 | 丹娜(天津)生物科技股份有限公司 | 一种改进的基于动态显色法的工业内毒素检测鲎试剂盒及其使用方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8827557D0 (en) * | 1988-11-25 | 1988-12-29 | Radiometer Corporate Dev Ltd | Process for handling horseshoe crab amoebocyte lysate |
JP3524120B2 (ja) * | 1992-05-08 | 2004-05-10 | 生化学工業株式会社 | 前処理剤、前処理方法、前処理された試料による測定法、測定用キット及び試料の判定方法 |
JP3242733B2 (ja) * | 1993-02-26 | 2001-12-25 | 生化学工業株式会社 | エンドトキシン特異的測定剤 |
CN102305788A (zh) * | 2010-11-22 | 2012-01-04 | 天津市一瑞生物工程有限公司 | 革兰阴性菌脂多糖(内毒素)比色检测试剂盒的制备及其使用方法 |
CN102866255B (zh) * | 2012-09-13 | 2014-12-24 | 莫水晶 | 一种人体液真菌(1,3)-β-D葡聚糖检测试剂盒及其应用方法 |
-
2014
- 2014-04-24 CN CN201410166572.7A patent/CN105021817B/zh active Active
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104483495A (zh) * | 2014-11-13 | 2015-04-01 | 湛江安度斯生物有限公司 | 一种消除g试验假阳性干扰的方法 |
CN106290890A (zh) * | 2016-07-15 | 2017-01-04 | 科赫生物科技(北京)有限公司 | 一种改良的人体液显色法真菌1,3‑β‑D‑葡聚糖检测试剂盒及其应用方法 |
CN106290890B (zh) * | 2016-07-15 | 2018-10-23 | 科赫生物科技(北京)有限公司 | 一种改良的人体液显色法真菌1,3-β-D-葡聚糖检测试剂盒及其应用方法 |
CN106974876A (zh) * | 2017-03-14 | 2017-07-25 | 天津喜诺生物医药有限公司 | 一种由鲎细胞裂解液制备眼部护理液的方法 |
CN108663509A (zh) * | 2017-06-16 | 2018-10-16 | 江苏诺鬲生物科技有限公司 | 一种标记真菌的免疫显色试剂 |
CN108642131A (zh) * | 2018-04-17 | 2018-10-12 | 山东仕达思生物产业有限公司 | 一种凝固酶检测试剂、反应垫及其制备方法和试剂盒 |
CN109868216A (zh) * | 2019-04-01 | 2019-06-11 | 丹娜(天津)生物科技有限公司 | 一种简化的真菌1-3-β-D葡聚糖检测试剂盒 |
CN112625145A (zh) * | 2020-11-25 | 2021-04-09 | 昆明思安生物科技有限公司 | 1,3-β-D葡聚糖衍生物、试剂盒及制备方法及测定1,3-β-D葡聚糖含量的方法 |
CN113092767A (zh) * | 2021-04-02 | 2021-07-09 | 丹娜(天津)生物科技股份有限公司 | 一种鲎试剂冻干微球及其制备方法和应用 |
CN113092767B (zh) * | 2021-04-02 | 2024-03-12 | 丹娜(天津)生物科技股份有限公司 | 一种鲎试剂冻干微球及其制备方法和应用 |
CN115236337A (zh) * | 2022-09-21 | 2022-10-25 | 丹娜(天津)生物科技股份有限公司 | 一种改进的基于动态显色法的工业内毒素检测鲎试剂盒及其使用方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105021817B (zh) | 2017-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105021817A (zh) | 一种人体液的显色法真菌1,3-β-D-葡聚糖检测试剂盒 | |
CN106290890B (zh) | 一种改良的人体液显色法真菌1,3-β-D-葡聚糖检测试剂盒及其应用方法 | |
CN102864208B (zh) | Av/bv联合检测试剂盒的质控品及其制备方法 | |
CN104316685B (zh) | 一种二乙酰精胺的检测试剂盒及制备方法和应用 | |
CN102866255B (zh) | 一种人体液真菌(1,3)-β-D葡聚糖检测试剂盒及其应用方法 | |
CN104090105A (zh) | 一种检测hev抗体的方法及试剂盒和该试剂盒的制备方法 | |
Bauer et al. | Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers | |
CN109374384A (zh) | 一种荧光染色试剂 | |
CN101539576A (zh) | 乙型肝炎病毒前s1抗原化学发光免疫分析测定试剂盒及其制备方法 | |
CN101063176A (zh) | 一种同时检测牛轮状病毒与牛病毒性腹泻病毒的双重rt-pcr方法及专用试剂盒 | |
CN102305788A (zh) | 革兰阴性菌脂多糖(内毒素)比色检测试剂盒的制备及其使用方法 | |
CN106596958A (zh) | 布鲁氏菌病cf‑elisa抗体检测试剂盒 | |
CN103773737A (zh) | 抗ca199单克隆抗体产生的杂交瘤及化学发光免疫分析试剂盒的制备 | |
CN104931314A (zh) | 一种粪便样品的处理方法及其应用 | |
CN106319028A (zh) | 用于检测解脲支原体和人型支原体的试剂盒 | |
CN104411833A (zh) | 应用maldi-toff质谱分析法的侵染性真菌感染的体外诊断方法 | |
CN203965445U (zh) | 一种动态显色法内毒素检测鲎试剂盒 | |
CN107449909B (zh) | 一种用于活动性结核诊断的蛋白芯片及试剂盒 | |
CN103033631A (zh) | 利用卵黄脂磷蛋白抗体定性检测鱼类卵黄原蛋白的试剂盒 | |
CN106932574B (zh) | B型链球菌感染的检测方法 | |
CN102809653A (zh) | 一种检测新布尼亚病毒抗原的elisa试剂盒的制备和应用 | |
CN104698159A (zh) | 一种内毒素含量的检测方法 | |
CN102181438A (zh) | 一种核苷酸检测序列及其检测方法 | |
CN204359795U (zh) | 螨特异性IgG4亚型抗体检测试剂盒 | |
CN104730233B (zh) | 一种elisa检测中的血清稀释液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180930 Address after: 300467 Room 101, 1 building, 14 office building, No. 2018 Tian Tian Road, Tianjin ecological city, Tianjin, 3B (-2). Patentee after: DYNAMIKER BIOTECHNOLOGY (TIANJIN) Co.,Ltd. Address before: 14th Floor N1406, Experimental Building of Tianjin International Institute of Biomedicine, 220 Dongting Road, Tianjin Development Zone, Tianjin Patentee before: TIANJIN HUIBIN BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Song Yu Inventor after: Wang Baoxue Inventor after: Li Ning Inventor after: Wang Dongdong Inventor after: Su Yan Inventor after: Zhou Zeqi Inventor before: Song Yu Inventor before: Wang Baoxue Inventor before: Li Ning Inventor before: Wang Dongdong Inventor before: Li Yan Inventor before: Zhou Zeqi |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300467 Room 101, 1 building, 14 office building, No. 2018 Tian Tian Road, Tianjin ecological city, Tianjin, 3B (-2). Patentee after: Dana (Tianjin) Biotechnology Co.,Ltd. Address before: 300467 Room 101, 1 building, 14 office building, No. 2018 Tian Tian Road, Tianjin ecological city, Tianjin, 3B (-2). Patentee before: DYNAMIKER BIOTECHNOLOGY (TIANJIN) Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 300467 Building 2, Rongzhi Industrial Park, 3667 Zhongbin Avenue, Zhongxin ecological city, Binhai New Area, Tianjin Patentee after: Dana (Tianjin) Biotechnology Co.,Ltd. Address before: 300467 Room 101, 1 building, 14 office building, No. 2018 Tian Tian Road, Tianjin ecological city, Tianjin, 3B (-2). Patentee before: Dana (Tianjin) Biotechnology Co.,Ltd. |